Miki C - Search Results

1

Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.

Toiyama Y, Tanaka K, Konishi N, Mohri Y, Tonouchi H, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: miki c. Cancer Chemother Pharmacol. 2006 Feb;57(3):368-75. doi: 10.1007/s00280-005-0057-9. Epub 2005 Aug 2. Cancer Chemother Pharmacol. 2006. PMID: 16075279

2

in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.

Inoue Y, Tanaka K, Hiro J, Yoshiyama S, Toiyama Y, Eguchi T, Miki C, Kusunoki M. Inoue Y, et al. Among authors: miki c. Int J Oncol. 2006 Feb;28(2):479-86. Int J Oncol. 2006. PMID: 16391804

3

The range of optimal concentration and mechanisms of paclitaxel in radio-enhancement in gastrointestinal cancer cell lines.

Toiyama Y, Inoue Y, Hiro J, Ojima E, Watanabe H, Narita Y, Hosono A, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: miki c. Cancer Chemother Pharmacol. 2007 May;59(6):733-42. doi: 10.1007/s00280-006-0327-1. Epub 2006 Sep 7. Cancer Chemother Pharmacol. 2007. PMID: 16957932

4

The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines.

Ojima E, Inoue Y, Watanabe H, Hiro J, Toiyama Y, Miki C, Kusunoki M. Ojima E, et al. Among authors: miki c. Oncol Rep. 2006 Nov;16(5):1085-91. Oncol Rep. 2006. PMID: 17016597

5

Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.

Inoue Y, Miki C, Watanabe H, Hiro J, Toiyama Y, Ojima E, Yanagi H, Kusunoki M. Inoue Y, et al. Among authors: miki c. J Gastroenterol. 2006 Dec;41(12):1149-57. doi: 10.1007/s00535-006-1904-0. Epub 2007 Feb 6. J Gastroenterol. 2006. PMID: 17287894

6

Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer.

Hiro J, Inoue Y, Toiyama Y, Yoshiyama S, Tanaka K, Mohri Y, Miki C, Kusunoki M. Hiro J, et al. Among authors: miki c. Oncol Rep. 2010 Oct;24(4):1029-34. doi: 10.3892/or.2010.1029. Oncol Rep. 2010. PMID: 20811685

7

Mitotic checkpoint genes, hsMAD2 and BubR1, in oesophageal squamous cancer cells and their association with 5-fluorouracil and cisplatin-based radiochemotherapy.

Tanaka K, Mohri Y, Ohi M, Yokoe T, Koike Y, Morimoto Y, Miki C, Tonouchi H, Kusunoki M. Tanaka K, et al. Among authors: miki c. Clin Oncol (R Coll Radiol). 2008 Oct;20(8):639-46. doi: 10.1016/j.clon.2008.06.010. Epub 2008 Aug 8. Clin Oncol (R Coll Radiol). 2008. PMID: 18691855

8

5-FU improves p27-related poor prognosis in patients with Astler-Coller B2-C colorectal carcinoma.

Kobayashi M, Shiraishi T, Tonouchi H, Miki C, Kusunoki M. Kobayashi M, et al. Among authors: miki c. Oncol Rep. 2002 Jan-Feb;9(1):29-33. Oncol Rep. 2002. PMID: 11748451

9

Intra-tumoral interleukin-6 down-regulation system and genetic mutations of tumor suppressor genes in colorectal carcinoma.

Miki C, Tonouchi H, Wakuda R, Hatada T, Inoue Y, Minato E, Kobayashi M, Kusunoki M. Miki C, et al. Cancer. 2002 Mar 1;94(5):1584-92. doi: 10.1002/cncr.10324. Cancer. 2002. PMID: 11920517 Free article.

10

Vascular endothelial growth factor as an age-dependent prognostic factor in gastric cancer patients.

Minato E, Miki C, Tanaka K, Kobayashi M, Mohri Y, Tonouchi H, Kuribayashi K, Kusunoki M. Minato E, et al. Among authors: miki c. Am J Surg. 2002 Nov;184(5):460-4. doi: 10.1016/s0002-9610(02)01006-1. Am J Surg. 2002. PMID: 12433614

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters